Track topics on Twitter Track topics that are important to you
KSQ Therapeutics, a Cambridge, Mass.-based biotechnology that uses the genetic-engineering tool CRISPR to develop new drugs, has raised $80 million, it's second big raise in as many years. KSQ raised $76 million last October.
Original Article: CRISPR-Based Drugmaker Raises $80 MillionNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...